# Trade Mark Journal No.2025/043 24 October 2025

## WO0000001866123 (42)

Office of origin: United States of America

Date of International Registration:28 May 2025
Date of designation in the UK: 28 May 2025

International priority date claimed: 20 December 2024 (United States of America) (98915361)

Class 42
  Biological research; biological research and analysis; development of gene-based medicines; gene therapy research; laboratory research services in the field of gene expression; medical research; medical research services; research in the field of gene editing technology; research in the field of synthetic biology; software as a service (SaaS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; software as a service (SaaS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; providing laboratory research services in the field of gene expression, namely, cancer biology; testing, inspection, research, or development of pharmaceutical preparations for gene therapy.

Asymptote Genetic Medicines, Inc.

Representative: Jonathan Pearce SoCal IP Law Group LLP, 310 N Westlake Blvd., Suite 120, Westlake Village CA 91362, UNITED STATES OF AMERICA